Carna Biosciences Inc
TSE:4572

Watchlist Manager
Carna Biosciences Inc Logo
Carna Biosciences Inc
TSE:4572
Watchlist
Price: 455 JPY 2.25% Market Closed
Market Cap: ¥9.4B

Wall St Price Targets

Price Forecast
No price targets yet

We don't have analyst price targets for Carna Biosciences Inc yet.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Carna Biosciences Inc yet.

Carna Biosciences Inc Competitors:
Price Targets

Revenue
Forecast

1% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
1% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 4 years is 27%.

Gross Profit
Forecast

2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Carna Biosciences Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Carna Biosciences Inc

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Carna Biosciences Inc's stock price target?
Not Available

Carna Biosciences Inc does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Carna Biosciences Inc?
Projected CAGR
27%

Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 4 years is 27%.

Back to Top